BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9512875)

  • 1. Effect of hypotensive drugs on the circadian blood pressure pattern in essential hypertension: a comparative study.
    Zakopoulos N; Stamatelopoulos S; Moulopoulos S
    Cardiovasc Drugs Ther; 1997 Dec; 11(6):795-9. PubMed ID: 9512875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Mancia G; Omboni S; Parati G;
    J Hypertens; 2002 Mar; 20(3):545-53. PubMed ID: 11875324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa.
    Sareli P; Radevski IV; Valtchanova ZP; Libhaber E; Candy GP; Den Hond E; Libhaber C; Skudicky D; Wang JG; Staessen JA
    Arch Intern Med; 2001 Apr; 161(7):965-71. PubMed ID: 11295959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
    Pelttari LH; Hietanen EK; Salo TT; Kataja MJ; Kantola IM
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):272-9. PubMed ID: 9544866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of perindopril and the diuretic combination amiloride+hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients.
    Kool MJ; Lustermans FA; Breed JG; Struyker Boudier HA; Hoeks AP; Reneman RS; Van Bortel LM
    J Hypertens; 1995 Aug; 13(8):839-48. PubMed ID: 8557961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
    Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
    Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group.
    Os I; Hotnes T; Dollerup J; Mogensen CE
    Am J Hypertens; 1997 Aug; 10(8):899-904. PubMed ID: 9270085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients--assessment by spectral analysis of heart rate and blood pressure variability.
    Salo TM; Kantola I; Voipio-Pulkki LM; Pelttari L; Viikari JS
    Eur J Clin Pharmacol; 1999 May; 55(3):191-8. PubMed ID: 10379634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea.
    Kraiczi H; Hedner J; Peker Y; Grote L
    Am J Respir Crit Care Med; 2000 May; 161(5):1423-8. PubMed ID: 10806134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of antihypertensive efficacy of perindopril: results of double-blind multicenter studies versus reference drugs.
    Thurston H; Desche P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S45-9. PubMed ID: 1725202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of different approaches to the treatment of arterial hypertension: combination treatment with low dose perindopril/indapamide versus sequential treatment of stepped-dose treatment].
    Andréjak M; Zannad F; Laville M; Duru G; Mourad JJ; Waeber B
    Therapie; 2003; 58(4):351-2. PubMed ID: 14679674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of regression of left ventricular hypertrophy to changes in ambulatory blood pressure after long-term therapy with perindopril versus nifedipine.
    Schulte KL; Meyer-Sabellek W; Liederwald K; van Gemmeren D; Lenz T; Gotzen R
    Am J Cardiol; 1992 Aug; 70(4):468-73. PubMed ID: 1386490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
    Magvanjav O; Gong Y; McDonough CW; Chapman AB; Turner ST; Gums JG; Bailey KR; Boerwinkle E; Beitelshees AL; Tanaka T; Kubo M; Pepine CJ; Cooper-DeHoff RM; Johnson JA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibition as first-line treatment for hypertension.
    Thurston H
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():67-71. PubMed ID: 1395119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    Am J Hypertens; 2007 Jun; 20(6):699-704. PubMed ID: 17531931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and dynamic interactions of the angiotensin-converting enzyme inhibitor imidapril with hydrochlorothiazide, bisoprolol and nilvadipine.
    Breithaupt-Grögler K; Ungethüm W; Meurer-Witt B; Belz GG
    Eur J Clin Pharmacol; 2001 Jul; 57(4):275-84. PubMed ID: 11549204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with Perindopril.
    Letellier P; Overlack A; Agnes E; Desche P
    J Hum Hypertens; 1994 Feb; 8(2):145-9. PubMed ID: 8207741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.